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1. Introduction 
We have shown previously [l] that pyrazole 
administration to rats inhibits the hepatic activity of 
tryptophan oxygenase [EC 1.13.1.121 probably by 
reducing the degree of heme saturation of the 
apoenzyme and thus the enzyme biosynthesis. As 
pyrazole also affects catalase [EC 1.11.1.61 [2] , a 
specific effect of this compound on hemoprotein 
enzymes was suggested. However, the data obtained 
did not allow us, to exclude a more general effect of 
pyrazole on enzyme synthesis. 
It seemed therefore of interest to test whether 
pyrazole also affects the activity of tyrosine amino- 
transferase [EC 2.6.1.51, enzyme which, although 
requiring pyridoxal phosphate and not heme, has, 
like tryptophan oxygenase, a rapid turn-over in the 
liver [3] and is also inducible by cortisol [4]. 
The present results show that pyrazole administra- 
tion to rats modify the induction time course of 
tyrosine aminotransferase by cortisol in a way which 
is similar to that described after administration of 
known inhibitors of protein synthesis [5,6]. 
2. Materials and methods 
Female Wistar rats, weighing 150 + 5 g, maintained 
on a standard laboratory diet and fasted during the 
overnight period immediately preceding the experi- 
ments were used. 
Pyrazole and cortisol 21-acetate were purchased 
from Sigma (St Louis, USA). 
Pyrazole (272 mg per kg body wt.) and/or cortisol 
North-Holland fiblishing Company - Amsterdam 
21-acetate (10 mg per rat) were injected intraperitone- 
ally and the animals killed at various times afterwards, 
as indicated in Results. Control rats received equi- 
valent volumes of saline. Pyrazole and cortisol, when 
both administered, were injected at the same time. 
The rats being sacrified by decapitation, the 
whole liver was exposed and frozen exactly one 
minute after decapitation for a better reproducibility 
of results. Tyrosine aminotransferase was determined 
according to Rosen et al. [7] and was expressed as 
micromoles of p-hydroxyphenylpyruvate formed per 
hour and per g liver wet weight. 
All results are given as mean values 5 S.E.M. and 
Student’s ‘t’ test was used for comparison of mean 
values. 
3. Results 
The effects of pyrazole administration on the 
basal tyrosine aminotransferase activity are shown 
in fig. 1. Whereas the enzyme activity is unaltered 
4 and 8 h after treatment, a significant increase (70%) 
appears 18 h after this treatment. 
In order to test whether pyrazole affects the level 
of tyrosine aminotransferase ffecters, we used the 
mixed homogenate technique, as described by 
Greengard [8]. The results (table 1) show that the 
enzyme activity experimentally determined in the 
mixed homogenates is identical to the theoretical 
value, thus excluding this possibility. 
The effects of pyrazole on the induction of 
tyrosine aminotransferase by cortisol are shown in 
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Fig.1. Effects of pyrazole administration on rat liver tyrosine 
aminotransferase. Pyrazole (272 mg per kg body wt.) was 
injected at zero time. The enzyme activity is expressed as 
percentage of the mean activity found at the same time in 
control saline injected rats. Number of animals: 5 in each 
group. Statistical significance: t p > 0.05, ** p < 0.01. 
flg.2. The results found 4 h after cortisol administra- 
tion show that pyrazole does not abolish tyrosine 
aminotransferase induction by cortisol, although it 
reduces it by about 20% (p < 0.01). 4 h later, tyrosine 
aminotransferase induced activity does not signifi- 
cantly differ whether or not pyrazole is administered 
together with cortisol. The results are quite different 
10 h later. As a matter of fact, at this time, the 
tyrosine aminotransferase activity drops back to the 
basal level in the control animals, treated with cortisol 
alone, whereas it is maintained at a very high level in 
the pyrazole plus cortisol treated rats. 
As shown by the mixed homogenate technique 
(table I), the effects of pyrazole on tyrosine amino- 
transferase induction are not mediated by changes in 
effecters of the enzyme activity. 
4. Discussion 
It was found in the present work that, during the 
first induction phase following cortisol administration, 
Table 1 
Tyrosine aminotransferase activity 4 and 18 h after pyrazole administration: mixed homogenate assay 
Hours after the 
treatment 
Single homogenates Mixed homogenates 
Experimental values Experimental values Theoretical values 
Non-induced A B A+B 
2 
4 
18 
185 f 34 163 f 20 167 f 10 174* 8 
p > 0.20 
118 % 26 203 f 18 162 * 17 160 f 17 
p > 0.80 
Induced C D C+D 
2 
4 
18 
527 f 60 424 f 30 488 f 45 489 f 42 
p > 0.30 
233 * 55 540 f 69 408 + 69 386 * 57 
p > 0.60 
The animals were given intraperitoneally either saline (A), pyrazole (272 mg per kg body wt.) (B), cortisol (10 mg/rat) and 
saline (C) or cortisol plus pyrazole CD). The enzyme activities were determined 4 or 18 h after the treatment and are expressed as 
micromoles of p-hydroxyphenylpyruvate formed per hour and per g liver wet weight. They represent he mean * S.E.M. of 5 rats 
in each group. The experimental values in the mixed homogenate assays refer to mixtures of equal volumes of homogenates (A) 
and (B) or (C) and (D). 
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TIME (HOURS) 
Fig.2. Effects of pyrazole administration on the cortisol 
mediated induction of rat liver tyrosine aminotransferase. At 
zero time the animals were given intraperitoneally either 
cortisol(10 mg/rat) and pyrazole (272 mg per kg body wt.) 
(- -A- -) or cortisol and saline (-•-). The enzyme activity 
was determined as described in the text and expressed as 
percentage of the activity found at the same time in 5 control 
saline injected rats. Each point represents the mean value 
f S.E.M. for 5 rats. 
pyrazole reduces by about 20% the activity of tyrosine 
aminotransferase. This slight inhibition contrasts with 
the strong reduction (80%) of the tryptophan oxy- 
genase activities found previously [ 1 ] during this 
induction phase, which is characterized by rapid 
enzyme synthesis [9] . The same discrepancy between 
the effects on tyrosine aminotransferase and on 
tryptophan oxygenase has been reported during 
studies concerned with the effects of inhibitors of 
protein synthesis such as 8azaguanine [ 10,l l] , 
Hluoroorotate [ 51 or small doses of cycloheximide 
[6] on the induction of these enzymes following 
cortisol administration. The similarity between the 
results obtained with pyrazole and with known 
inhibitors of protein synthesis suggests that pyrazole 
inhibits the enzyme synthesis during the first induc- 
tion phase, tryptophan oxygenase being much more 
sensitive to this inhibition than tyrosine aminotrans- 
ferase. 
During the late induction phase (inactivation 
phase), the activity of tyrosine aminotransferase is 
maintained at/or near the induced level in the pyra- 
zole plus cortisol treated animals, whereas it drops 
back to the basal level in the control rats injected 
with cortisol alone. Similar results have been again 
reported when studying the effects of 8-azaguanine 
[I l] or Wluoroorotate [5] on the late phase of 
tyrosine aminotransferase induction. The increased 
basal tyrosine aminotransferase activity found 18 h 
after pyrazole administration also occurs from 12 to 
24 h after cycloheximide treatment [6]. 
The elevated aminotransferase activity observed 
18 h after pyrazole treatment as well as during the 
late induction phase following pyrazole plus cortisol 
administration could result from a decreased synthesis 
either of the repressor acting on the translation of 
messenger RNA, as suggested by Tomkins et al. [ 121, 
or of the polypeptides specifically required for the 
removal of the enzyme, as suggested by Kenney et al. 
[131* 
Our data suggest hat pyrazole administration 
results in a disturbance of enzyme synthesis which 
is not restricted to hemoprotein enzymes. This 
effect should be kept in mind when pyrazole is used 
in vivo, especially during the course of investigations 
concerned with alcohol metabolism. 
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